Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: J Trauma Acute Care Surg. 2022 Jan 1;92(1):159–166. doi: 10.1097/TA.0000000000003410

Figure 2.

Figure 2.

The α-globin chain augments plasmin activity. Plasmin activity is shown as a function of treatment group. The plasma alone demonstrates a baseline amount of plasmin activity. The addition of 75 ng/ml of tPA induced a significant increase over the plasma alone. The addition of 5 μg of the α-globin chain significantly increased the plasmin activity in response to tPA. In contrast the addition of the protease inhibitor PMSF [50 nM] significantly inhibited tPA-induced plasmin activity (n=7, *p<0.05 from Control, † p<0.05 from tPA).